James R. McNab, Director at TITAN PHARMACEUTICALS INC (TTNP), bought 20,000 shares at $7.03 ($141K) on 2016-05-31, disclosed to the SEC on 2016-05-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CRIS | SELL | 2017-05-02 | $466K | — | Filing → |
| CRIS | SELL | 2017-04-27 | $618K | — | Filing → |
| CRIS | SELL | 2017-04-27 | $571K | — | Filing → |